We Operate Exclusive Clinical Trial Investigative Sites In Asia
CLINICAL INVESTIGATIVE SITES
DELTA HEALTH collaborates with partner companies and healthcare organizations for managing clinical trial investigative sites based on the maxim.....EXPERIENCE.....INTEGRITY....QUALITY.
We have long-term exclusivity agreements with prominent teaching hospitals and clinics in Asia to operate state-of-the-art clinical investigative sites having extensive experience in conducting international drug development clinical trials according to GCP-ICH standards. These investigative sites covering a catchment area population of 10 million plus, have preferred access to a fast growing local potential clinical trial subject populace.
The North American audited and qualified investigative sites in Asia, primarily focused on conducting Phase 1, Phase 2 and Phase 3 clinical trials, are directly managed by the DELTA HEALTH team members who have been involved in leading multiple global drug development clinical programs that have resulted in regulatory approvals from the United States FDA and Health Canada.
For further information please contact: